News
2025
April 21, 2025
Scientific Industries Secures New Funding to Advance its SBI Bioprocessing Division
VIEW PRESS RELEASEMarch 7, 2025
Medicus Pharma Ltd. Announces Pricing of $4.2 Million Regulation A Offering
VIEW PRESS RELEASEMarch 1, 2025
Sonendo, Inc. Announces $5.0 Million Private Placement
VIEW PRESS RELEASEJanuary 13, 2025
NAYA Biosciences Announces Pricing of $9.5 Million Public Offering
VIEW PRESS RELEASE2024
December 24, 2024
OS Therapies Announces Pricing of $6 Million Private Placement
VIEW PRESS RELEASEDecember 24, 2024
Carmell Announces PIPE Investment From Existing and New Investors To Support Commercial Build-out
VIEW PRESS RELEASEDecember 23, 2024
MAXONA Pharmaceuticals Closes on $6,960,500 Series B Convertible Preferred Stock Offering
VIEW PRESS RELEASEDecember 19, 2024
Marker Therapeutics Announces $16.1 Million Private Placement
VIEW PRESS RELEASENovember 21, 2024
Intensity Therapeutics, Inc. Announces Pricing of $3 Million Registered Direct Offering and Concurrent Private Placement
VIEW PRESS RELEASE2023
December 27, 2023
Media and entertainment SPAC Iron Horse Acquisitions prices upsized $61 million IPO
VIEW PRESS RELEASENovember 10, 2023
AI Transportation Acquisition Corp Announces Pricing Of $60,000,000 Initial Public Offering
VIEW PRESS RELEASEOctober 31, 2023
Aileron Therapeutics Announces Acquisition of Lung Therapeutics
VIEW PRESS RELEASEOctober 11, 2023
Quetta Acquisition Corporation Announces Closing of $69 Million Initial Public Offering
VIEW PRESS RELEASEOctober 2, 2023
SAB Biotherapeutics Announces Private Placement of up to $130 Million to Advance Development of Lead Drug Candidate for Type 1 Diabetes
VIEW PRESS RELEASE2022
December 23, 2022
IceCure Medical Ltd. Announces Closing of $14.5 Million Public Offering Priced At-The-Market Under Nasdaq Rules
VIEW PRESS RELEASEDecember 23, 2022
Outlook Therapeutics® Enters Definitive Agreement for $31.8 Million Unsecured Convertible Promissory Note
VIEW PRESS RELEASEDecember 7, 2022
SAB Biotherapeutics Announces $7.9 Million Private Placement of Common Stock
VIEW PRESS RELEASEDecember 7, 2022
X4 Pharmaceuticals Prices $65.0 Million Public Offering
VIEW PRESS RELEASENovember 30, 2022
CNS Pharmaceuticals Announces Pricing of $6.0 Million Public Offering At a Premium to the Market Closing Price
VIEW PRESS RELEASE2021
December 21, 2021
Larkspur Health Acquisition Corp. Prices $75 Million Initial Public Offering
VIEW PRESS RELEASEDecember 15, 2021
Ault Disruptive Technologies Corporation Prices $100 Million Initial Public Offering
VIEW PRESS RELEASEDecember 13, 2021
IceCure Medical LTD. Closes $17 Million Underwritten Public Offering
VIEW PRESS RELEASEDecember 13, 2021
Alpha Star Acquisition Prices $100M IPO
VIEW PRESS RELEASEDecember 08, 2021
Inception Growth Acquisition Limited Announces Pricing of $90,000,000 Initial Public Offering
VIEW PRESS RELEASE2020
October 29, 2020
Forte Biosciences Announces Pricing of $40.0 Million Public Offering of Common Stock
VIEW PRESS RELEASESeptember 11, 2020
Creatd, Inc., Formerly Jerrick Media Holdings, Inc., Announces Pricing of $7,762,500 Public Offering
VIEW PRESS RELEASEAugust 27, 2020
Nuveen Dynamic Municipal Opportunities Fund Attracts $780.0 Million
VIEW PRESS RELEASEAugust 22, 2020
CohBar Announces Pricing of $15.0 Million Public Offering of Common Stock and Warrants
VIEW PRESS RELEASEAugust 10, 2020
NervGen Pharma Corp. Completes $6.45 Million Public Offering
VIEW PRESS RELEASE2019
December 23, 2019
Monopar Therapeutics Inc. Announces Closing of Initial Public Offering of Common Stock
VIEW PRESS RELEASEDecember 12, 2019
SCYNEXIS Announces Closing of $35 Million Public Offering of Common Stock and Warrants
VIEW PRESS RELEASEOctober 22, 2019
Union Acquisition Corp. II Announces Closing of $200 Million Initial Public Offering
VIEW PRESS RELEASESeptember 26, 2019
Vaxart Announces Pricing of $8 Million Underwritten Public Offering
VIEW PRESS RELEASEAugust 6, 2019
BioCardia Announces Closing of $10.0 Million Public Offering
VIEW PRESS RELEASE
